Notice of August, 2024 Registration Exams for Pharmacy Personnel

The Pharmacy and Medicines Regulatory Authority (PMRA) hereby announces that registration examinations for Pharmacists, Pharmacy Technologists and Pharmacy Assistants will be administered as follows:

 MZUZULILONGWEBLANTYRE
Time08h0008h0008h00
Date (s)1st – 2nd August, 20241st – 2nd August, 20241st – 2nd August, 2024
VenueGrand Palace HotelCrossroads HotelVictoria Hotel

Eligible candidates who are interested to sit for these examinations are requested to confirm to PMRA by submitting duly filled registration application form with all required documents not later than 17h00 of 13th July, 2024.

Application forms for both new applicants as well as those resitting the examinations, can be accessed on PMRA website www.pmra.mw or directly from PMRA office’s reception.

For further information and/or clarification please contact PMRA on 0999 708 450 / 0881 790 993/0999379544 or email at info@pmra.mw.

PMRA, MACRA court dealers of traditional medicines, broadcasters on TCM adverts

The Pharmacy and Medicines Regulatory Authority (PMRA) and Malawi Communications Regulatory Authority (MACRA) have jointly held orientation meetings with dealers of traditional and complementary medicines (TCM) and broadcasters in Blantyre, Lilongwe and Mzuzu on advertisement and promotion of traditional medicines.

The two organisations were in Blantyre on Tuesday, Lilongwe on Thursday and Mzuzu on Friday to orient the TCM dealers and owners of broadcasting media houses on the regulation of advertisement and promotion of traditional medicines as provided for in the PMRA Act, 2019.

Section 68 (2) of the PMRA Act states that advertisement of any medicine or allied substance shall require prior screening and approval by the Authority.

Speaking when he presided over the orientation meeting in Blantyre, Allied Substances Sub-Committee Chairperson Bright Lipenga said regulation of the TCM products advertisements was aimed at ensuring that only true information is being disseminated to the public and that the public makes informed decisions based on this true information.

Said Lipenga: “Production of traditional and complementary medicines at industrial scale has resulted in the need for advertisement and promotion of the same.

“Considering that these advertisements are for specialised products and main target are vulnerable people, some of them who are in a desperate need to be helped, there is a need to regulate information being disseminated to the public.”

On his part, MACRA’s Deputy Director of Broadcasting, Kelton Masangano echoed Lipenga’s sentiments saying the Communications Act, 2016 also empowers MACRA to regulate broadcast media content including advertisements hence his organisation’s decision to work with PMRA on the enforcement of regulation of TCM products advertisements.

PMRA and MACRA in November last year signed a memorandum of understanding (MoU) on collaboration on advertisement and promotion of traditional medicines with the overall objective to jointly oversee operationalisation of the requirement of the PMRA Act to have all advertisements traditional medicines vetted before they are broadcast.

Mrs. Frider Chimimba – Board Chairperson

Mrs. Frider Chimimba is the current Board Chairperson of the Board of Directors of the Pharmacy and Medicines Regulatory Authority.

Mr. Chance Munthali – Vice Board Chairperson

Mr. Chance Munthali is the current Vice Chairperson of the Board of Directors of the Pharmacy and Medicines Regulatory Authority (PMRA), Chairperson of the Pharmacy Sub-Committee and a member of the Finance and Administration (F & A) Sub-Committee of the Board.

Dr. Enock Ludzu – Member

Dr. Enock Ludzu is a member of the current Board of Directors of the Pharmacy and Medicines Regulatory Authority (PMRA). He’s also the current Chairperson of the Clinical Trial Review Sub-Committee of the Board. The Clinical Trial Review Committee is established in accordance with Section 17 of the PMRA Act, No. 9 of 2019 as a Sub-Committee of the Medicines Committee to, among other functions, advise the Authority on matters related to authorization and monitoring of clinical trials.

Mr. John Mhango – Member

Mr. John Mhango is a member of the current Board of Directors of the Pharmacy and Medicines Regulatory Authority (PMRA) and Chairperson of the Medicines Safety and Quality Monitoring Technical Committee of the Board. The Medicines Safety and Quality Monitoring Technical Committee is established in line with Section 17 of the PMRA Act, No. 9 of 2019 to advise the Authority on matters relating to medicine safety.

Mr. William Mpute – Member

Mr. William Mpute is a member of the current Board of Directors of the Pharmacy and Medicines Regulatory Authority (PMRA). He’s a qualified pharmacist and the current President of the Pharmaceutical Society of Malawi (PHASOM). He’s also Chairperson of the Medicines Sub-Committee of the PMRA Board. The Medicines Committee is established in line with Section 17 of the PMRA Act, No. 9 of 2019 to, among others, advise the Board on matters relating to medicines.

Dr. Marvin Phonera – Member

Dr. Marvin Phonera is member of the current Board of Directors of the Pharmacy and Medicines Regulatory Authority (PMRA), Chairperson of the Allied Substances Sub-Committee and member of the Medicines Sub-Committee of the Board.

Ms. Mary Kamtimaleka Chinkhadze – Member

Mrs. Mary Chinkhadze Kamtimaleka is member of the current Board of Directors of the Pharmacy and Medicines Regulatory Authority (PMRA) and Chairperson of the Finance and Administration Committee of the Board.

Mrs. Flossy Lombola – Member

Mrs. Flossy Lombola is member of the current Board of Directors of the Pharmacy and Medicines Regulatory Authority (PMRA) and also a member of the Allied Substances Sub-Committee of the Board. The Allied Substances Committee is established in accordance with Section 17 of the PMRA Act, No. 9 of 2019 to, among other functions, provide technical and scientific advice to the Authority on matters related to regulation of allied substances.